I noticed an easy-to-misread term in the announcement about the collaboration between Babylon and Aegis: fixed interest rate. The official statement says that the two parties plan to combine Trustless Bitcoin Vaults, Aave v4, and Aegis’ fixed-rate lending facility, with the goal of providing the product in Q4 2026, and still subject to completion of development and testing. In other words, this is not an already-live yield solution, and it’s not a quote that can be locked in right now.
What a fixed interest rate locks in is a portion of the financing cost over a certain term—not all the risk of the entire position. Here’s a purely computational example: suppose you borrow 100,000 USDT for 90 days at a fixed annual interest rate of 8%. Using simple interest, the interest would be about 1,973 USDT. That number only shows that the interest rate doesn’t fluctuate with the capital utilization rate; the actual product may still involve term, early repayment, fees, and maturity handling. The official has not published these parameters, so you can’t fill them in yourself.
More importantly, the BTC price is not fixed. The Health Factor of the position may still change with the collateral price, oracle quotes, and borrowing parameters. Even if the borrowing interest rate stays unchanged from start to finish, a sharp drop in BTC could still trigger liquidation. Moreover, each Vault in the TBV corresponds to an independent UTXO, so liquidation is still affected by the vaults’ granularity. Understanding “interest is predictable” as “it won’t get liquidated” are two entirely different issues.
This division of responsibilities is actually quite clear: @BabylonLabs_io provides the native BTC-collateral infrastructure, Aave handles the lending market, and Aegis converts floating-rate capital costs into fixed quotes for a specific term. What it solves is budget predictability—especially for institutions, funds, or market makers that need to account for capital costs in advance. When market capital costs rise, fixed quotes let borrowers assess ahead of time whether the expected strategy returns can cover the interest. But it does not replace the user in bearing price risk.
So I’ll wait for the formal product announcement and then closely verify five key data points: the true fixed annual interest rate, the term, early repayment rules, all fees, and liquidation parameters. For ordinary participants, when comparing products you should calculate the “total cost to maturity,” not just focus on a single APR. For $BABY , what’s really worth watching in this collaboration is whether TBV can evolve from a test-stage collateral mechanism into credit infrastructure where someone is willing to keep borrowing on an explicitly defined term and cost.
#baby
What a fixed interest rate locks in is a portion of the financing cost over a certain term—not all the risk of the entire position. Here’s a purely computational example: suppose you borrow 100,000 USDT for 90 days at a fixed annual interest rate of 8%. Using simple interest, the interest would be about 1,973 USDT. That number only shows that the interest rate doesn’t fluctuate with the capital utilization rate; the actual product may still involve term, early repayment, fees, and maturity handling. The official has not published these parameters, so you can’t fill them in yourself.
More importantly, the BTC price is not fixed. The Health Factor of the position may still change with the collateral price, oracle quotes, and borrowing parameters. Even if the borrowing interest rate stays unchanged from start to finish, a sharp drop in BTC could still trigger liquidation. Moreover, each Vault in the TBV corresponds to an independent UTXO, so liquidation is still affected by the vaults’ granularity. Understanding “interest is predictable” as “it won’t get liquidated” are two entirely different issues.
This division of responsibilities is actually quite clear: @BabylonLabs_io provides the native BTC-collateral infrastructure, Aave handles the lending market, and Aegis converts floating-rate capital costs into fixed quotes for a specific term. What it solves is budget predictability—especially for institutions, funds, or market makers that need to account for capital costs in advance. When market capital costs rise, fixed quotes let borrowers assess ahead of time whether the expected strategy returns can cover the interest. But it does not replace the user in bearing price risk.
So I’ll wait for the formal product announcement and then closely verify five key data points: the true fixed annual interest rate, the term, early repayment rules, all fees, and liquidation parameters. For ordinary participants, when comparing products you should calculate the “total cost to maturity,” not just focus on a single APR. For $BABY , what’s really worth watching in this collaboration is whether TBV can evolve from a test-stage collateral mechanism into credit infrastructure where someone is willing to keep borrowing on an explicitly defined term and cost.
#baby